High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial (Q73183259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J F Tisdale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D E Dunn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Geller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Plante

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

O Nunez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A J Barrett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T J Walsh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S J Rosenfeld

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N S Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1554-1559

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Late clonal diseases of treated aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Recovery from aplastic anemia after treatment with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

The pathophysiology of acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Correlation of clinical and immunologic states in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Current therapies for systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Antithymocyte globulin for patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Infection and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

Screening of cytotoxic drugs for residual bone marrow damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903126-3

7 January 2021

10.1016/S0140-6736(00)03126-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11075769%20AND%20SRC:MED&resulttype=core&format=json